![](https://investorshub.advfn.com/uicon/792403.png?cb=1632160976)
Monday, September 19, 2022 10:29:58 PM
Of course a question can be backed up with links? That's what makes a question informed, yes? Anyway, here are a couple of links that do provide a basis in something cite-able?
On October 7, 2021, the Company entered into a MDSA and PSA with Samsung Biologics Co., Ltd to advance the development of the Company’s human clone antibody program and clinical testing.
Quarterly Report for period 06.30.2022, page 12
After confirming antibody activity, the Company's CDMO partner Samsung Biologics produces recombinant antibodies in their proprietary, FDA-approved stable CHO cell line suitable for Clinical Application.
Quarterly Report for period 06.30.2022, page 17
So as we can see, Samsung is still working with ENZC according to the 2022 Q2 filings, and they really do have an ongoing partnership?
.
Sometimes I edit my posts in the first 15 minutes. Refresh for the latest.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM